Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy ...

Scientists hope the device can help give patients more warning ahead of seizures and prevent potential injuries ...

Lieutenant Governor Sabina Matos joined hospital leaders and patients to highlight the need for blood donations in the new ...

Actor Chae Jong-hyeop donated 50 million won for epilepsy patients. The Korea Epilepsy Association donated on the 7th "Actor ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the ...

A 'unique' AI-powered headset that can predict epileptic seizures minutes before they occur has been developed by scientists ...

Scientists have developed a "unique" AI-powered headset that can predict epileptic seizures minutes before they occur. The ...